RemeGen Co., Ltd. (OTCMKTS:REGMF) Short Interest Update

RemeGen Co., Ltd. (OTCMKTS:REGMF) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 196,500 shares, a drop of 42.3% from the February 28th total of 340,500 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days.

RemeGen Stock Performance

Shares of RemeGen stock opened at $1.50 on Monday. RemeGen has a twelve month low of $1.50 and a twelve month high of $4.00. The business’s fifty day moving average price is $1.50 and its 200 day moving average price is $1.51.

About RemeGen

RemeGen Co, Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in Mainland China and the United States. The company offers Telitacicept (RC18) for use in the treatment of systemic lupus erythematosus an autoimmune disease and Disitamab Vedotin (RC48) for use in the treatment of various cancers.